TRML

Tourmaline Bio, Inc.

15.19 USD
-0.11 (-0.72%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Tourmaline Bio, Inc. stock is up 12.94% since 30 days ago. The next earnings date is Aug 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 June’s closed higher than May.

About Tourmaline Bio, Inc.

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. Tourmaline Bio, Inc. was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was incorporated in 2002 and is based in New York, New York.